Company profile
Pathfinder Medical - Home
Pathfinder Medical is developing a novel electronic guidance system that will enable clinicians to connect blood vessels in a minimally invasive way.
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQ1NjE3NTI2NmFkaXF6a2N4
Published 24 Feb 2025 04:10
AP01 | Transaction MzQzMTYwNjk2NmFkaXF6a2N4
Published 09 Aug 2024 10:00
TM01 | Transaction MzQzMTYwNTk4MGFkaXF6a2N4
Published 08 Aug 2024 11:06
Company registered at Companies House
1 Dec 2024 to 31 May 2027
1 May 2023 to 28 Feb 2025
One of the most significant, costly, and growing world-wide health epidemics is the 422million people suffering from diabetes. Diabetes is the leading cause of kidney failure, a burdensome chronic condition, resulting in **3.4million patients requiring their blood to be routinely filtered externally through haemodialysis**. The current 'gold-standard' for...
1 Nov 2015 to 31 Oct 2016
Some 2.4m people worldwide have kidney conditions which require their blood to be routinely externally filtered. This haemodialysis treatment requires their circulatory (i.e. blood) system to be regularly connected to a dialysis machine. This requires patients to undergo a surgical procedure to prepare their vessels by forming a connection between an arte...
1 Feb 2015 to 31 Jul 2015
In patients with kidney failure a dialysis machine hooks up to a vascular access (VA) site to filter their blood. Currently, even the best method for VA has a high failure rate. A clogged access site presents a serious danger to the patient’s life and requires costly and potentially painful surgery to repair. Our novel catheter device creates a more relia...
